Brunei Darussalam vs North America: Immunization, measles second dose
Brunei Darussalam
99.0%
in 2024
North America
93.5%
in 2024
Brunei Darussalam rank
1st
North America rank
2nd
Immunization, measles second dose over time
- Brunei Darussalam
- North America
How they compare
Brunei Darussalam currently reports 99.0% against 93.5% in North America, a difference of 5.5%.
That makes Brunei Darussalam's figure about 1.1 times North America's.
Across all 25 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 1st and North America ranks 2nd of 178 countries.
Brunei Darussalam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | North America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 79.2% | 15.7% | Brunei Darussalam |
| 2010s | 95.8% | 90.3% | 5.5% | Brunei Darussalam |
| 2020s | 98.6% | 93.7% | 4.9% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Brunei Darussalam or North America?
- Brunei Darussalam, at 99.0% against 93.5% in North America as of 2024.
- What is the difference in immunization, measles second dose between Brunei Darussalam and North America?
- 5.5%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and North America?
- 25 years are reported by both, from 2000 to 2024.
- How do Brunei Darussalam and North America rank globally for immunization, measles second dose?
- Brunei Darussalam ranks 1st and North America ranks 2nd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.